Clinical analysis of 55 cases of primary small bowel adenocarcinoma
LIANG Li,MA Li-wen,XIAO Yu,ZHANG Yu,LI Hong-yan
DOI: https://doi.org/10.3781/j.issn.1000-7431.2009.06.020
2009-01-01
Tumor
Abstract:Objective:To investigate the clinical and pathologic features,treatment,prognosis,and related factors of primary small bowel adenocarcinoma.Methods: Retrospective analysis was performed on the clinical data from the 55 cases of primary small bowel adenocarcinoma.This study analyzed the correlation of clinical staging and chemotherapy with prognosis based on 33 patients who had complete follow-up data.Results:Intestinal malignant tumor occurred most in male patients.There were 36 men and 19 women with a median age of 61 years.Most tumors were originated in the duodenum(76.4%).Adenocarcinoma(78.2%) was the main pathological classification.The median survival period was 36 months for the 18 patients in stage Ⅰ and stage Ⅱ.The 1-,2-,and 5-years survival rates were 81.6%,68.0%,and 45.3%,respectively.The median survival period was 10 months for patients in stage Ⅲ and Ⅳ.The 1-and 2-year survival rates were 46.7% and 20.0%,respectively.The difference was significant between patients in different groups metioned above(P=0.010).The median survival time was 20 months for the patients who received chemotherapy(3 at stage Ⅱ,4 at stage Ⅲ,3 at stage Ⅳ).The 1-,2-and 5-year survival rates were 70.0%,40.0%,and 26.7%,respectively.The median survival time was 24 months for the patients who did not receive chemotherapy.The 1-,2-and 5-year survival rates were 68.7%,46.5%,and 34.9%,respectively.The difference was significant between the patients who received chemotherapy and those who did not receive chemotherapy(P=0.773).Conclusion:Primary small bowel adenocarcinoma occurred frequently in the duodenum.The patients with advanced primary small bowel adenocarcinoma had poor prognosis and low efficacy of chemotherapy.It will be beneficial to give proper chemotherapy to the patients with advanced primary small bowel adenocarcinoma.